Investors need to pay close attention to AEHR stock based on the movements in the options market lately.
Aehr's AI-driven burn-in demand, record backlog and sharp fiscal 2027 growth outlook strengthen its case over Camtek despite a richer valuation.
Aehr broadens beyond SiC as AI, silicon photonics and power semiconductors fuel a more diversified growth story.
Aehr's AI testing business gains momentum with major orders, new customer opportunities and a path toward recurring revenues.
Here is how Aehr Test Systems (AEHR) and Fortinet (FTNT) have performed compared to their sector so far this year.
Aehr's record backlog, AI-driven orders and strong fiscal 2027 outlook give it an edge over Cohu despite a higher valuation.
Aehr is betting on silicon photonics to drive sustained growth, as customer ramp ups and new orders are expected to support 15-20% of fiscal 2027 revenues.
Cooling inflation and softer jobs data have eased Fed rate-hike fears, fueling a strong rally in select growth and AI stocks.
Shares of Aehr Test Systems (NASDAQ:AEHR) are up roughly 8% in Friday midday, after a fresh Wall Street initiation lit another fire under one of 2026's most explosive small caps.
AEHR's $22M AI order underscores rising WLBI demand as chip complexity and costs increase, while backlog and bookings point to strong growth.
AEHR's 72.2% surge reflects record bookings, a $100.6M backlog and rising AI demand, but its premium valuation raises the stakes.
Shares of Aehr Test Systems (NASDAQ:AEHR) are up 6.1% in midday trading Tuesday, extending a torrid summer run in the semiconductor test equipment name.